Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C6H12O6 |
| Molecular Weight | 180.1561 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO
InChI
InChIKey=BJHIKXHVCXFQLS-UYFOZJQFSA-N
InChI=1S/C6H12O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3,5-9,11-12H,1-2H2/t3-,5-,6-/m1/s1
DescriptionSources: https://onlinelibrary.wiley.com/doi/abs/10.1002/adsc.200600356 |
http://onlinelibrary.wiley.com/doi/10.1002/14356007.a12_047.pub2/abstract |
https://www.ncbi.nlm.nih.gov/pubmed/26594441 |
https://books.google.ru/books?id=nZrwBwAAQBAJ&pg=PA59&lpg=PA59&dq=%22l-fructose%22&source=bl&ots=kAl43H3Ini&sig=ACfU3U3RmEF0Y1D8WrnNoe6kJdICbTywoQ&hl=en&sa=X&ved=2ahUKEwih49yMzL7hAhUlyaYKHa2JBNkQ6AEwEXoECDQQAQ#v=onepage&q=%22l-fructose%22%20sweetener&f=falsehttp://onlinelibrary.wiley.com/doi/10.1002/14356007.a12_047.pub2/abstract | https://www.ncbi.nlm.nih.gov/pubmed/12399260 | https://www.ncbi.nlm.nih.gov/pubmed/26567197 | https://www.ncbi.nlm.nih.gov/pubmed/26316589 | https://www.ncbi.nlm.nih.gov/pubmed/26856717 | https://www.ncbi.nlm.nih.gov/pubmed/23493541
Sources: https://onlinelibrary.wiley.com/doi/abs/10.1002/adsc.200600356 |
http://onlinelibrary.wiley.com/doi/10.1002/14356007.a12_047.pub2/abstract |
https://www.ncbi.nlm.nih.gov/pubmed/26594441 |
https://books.google.ru/books?id=nZrwBwAAQBAJ&pg=PA59&lpg=PA59&dq=%22l-fructose%22&source=bl&ots=kAl43H3Ini&sig=ACfU3U3RmEF0Y1D8WrnNoe6kJdICbTywoQ&hl=en&sa=X&ved=2ahUKEwih49yMzL7hAhUlyaYKHa2JBNkQ6AEwEXoECDQQAQ#v=onepage&q=%22l-fructose%22%20sweetener&f=falsehttp://onlinelibrary.wiley.com/doi/10.1002/14356007.a12_047.pub2/abstract | https://www.ncbi.nlm.nih.gov/pubmed/12399260 | https://www.ncbi.nlm.nih.gov/pubmed/26567197 | https://www.ncbi.nlm.nih.gov/pubmed/26316589 | https://www.ncbi.nlm.nih.gov/pubmed/26856717 | https://www.ncbi.nlm.nih.gov/pubmed/23493541
Fructose, or fruit sugar, is a simple ketonic monosaccharide found in many plants, where it is often bonded to glucose to form the disaccharide sucrose. At a commercial scale, fructose is often derived from sugar cane, sugar beets, and maize. Fructose is one of the three dietary monosaccharides, along with glucose and galactose, that are absorbed directly into the bloodstream. A growing body of research suggests that diet high in fructose may be contributing to incidences of obesity, insulin resistance, and diabetes.
CNS Activity
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease. | 2016-05 |
|
| Effect of dietary fructose on portal and systemic serum fructose levels in rats and in KHK-/- and GLUT5-/- mice. | 2015-11-01 |
|
| Direct renal effects of a fructose-enriched diet: interaction with high salt intake. | 2015-11-01 |
|
| Health implications of high-fructose intake and current research. | 2015-11 |
|
| Uptake and metabolism of fructose by rat neocortical cells in vivo and by isolated nerve terminals in vitro. | 2015-05 |
|
| Challenging the fructose hypothesis: new perspectives on fructose consumption and metabolism. | 2013-03-01 |
|
| Effects of fructose vs glucose on regional cerebral blood flow in brain regions involved with appetite and reward pathways. | 2013-01-02 |
|
| Fructose, weight gain, and the insulin resistance syndrome. | 2002-11 |
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT02590913
Twenty healthy volunteers were randomized into two groups: group A received 300 mL of 22.5% glucose and group B received 300 mL of 22.5% fructose. The solution was consumed after 8 hours of overnight fasting, the repeated with the opposite solution after a 1 week washout period. At each intervention venous blood was collected at 0, 0.5, 1, 2 and 3 hours, ad blood-pressure was recorded at 0, 1, 2, and 3 hours.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25708447
Nerve terminals were prepared from rat forebrains and purified synaptosomes were exposed to [U14C]fructose or [U14C]glucose for 10 minutes leading to the selective labeling of glutamate over aspartate and GABA, and Alanine. [U-14C]Fructose shoed a preference for labeling glutamate more strongly, and aspartate and GABA less strongly, than did [U-14C]glucose. Thus, the distribution of label between glutamate, aspartate, and GABA was significantly different in synaptosomes exposed to [U-14C]fructose or [U-14C]glucose, as reflected in an aspartate/glutamate labeling ratio of 0.07 and 0.53 and a GABA/glutamate labeling ratio of 0.03 and 0.36 for [U14C]fructose- and [U14C]glucose-exposed synaptosomes respectively. The increased labeling of glutamate indicates increased uptake of fructose into nerve terminals and oxidative fructose metabolism in these structures.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
LOINC |
48432-9
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
||
|
LOINC |
51593-2
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
||
|
WHO-VATC |
QV06DC02
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
||
|
LOINC |
13943-6
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
||
|
LOINC |
2297-0
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
||
|
LOINC |
2296-2
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
||
|
WHO-ATC |
V06DC02
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
||
|
LOINC |
34309-5
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
||
|
LOINC |
34308-7
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
||
|
LOINC |
49772-7
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
||
|
DSLD |
1322 (Number of products:48)
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
||
|
FDA ORPHAN DRUG |
28188
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
||
|
LOINC |
2295-4
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
||
|
LOINC |
10574-2
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
||
|
LOINC |
32240-4
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
||
|
LOINC |
34307-9
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
||
|
NCI_THESAURUS |
C68479
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
||
|
LOINC |
56624-0
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
||
|
LOINC |
15070-6
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
||
|
LOINC |
34194-1
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
28757
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
PRIMARY | |||
|
48095
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
PRIMARY | |||
|
6347-01-9
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
ALTERNATIVE | |||
|
C68480
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
PRIMARY | |||
|
10489-79-9
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
ALTERNATIVE | |||
|
15824
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
PRIMARY | |||
|
FRUCTOSE
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
PRIMARY | |||
|
200-333-3
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
PRIMARY | |||
|
SUB126925
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
PRIMARY | |||
|
1252
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
PRIMARY | |||
|
760385
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
PRIMARY | |||
|
6YSS42VSEV
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
PRIMARY | |||
|
SUB13925MIG
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
PRIMARY | |||
|
28645
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
PRIMARY | |||
|
100000078511
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
PRIMARY | |||
|
5984
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
PRIMARY | |||
|
CHEMBL604608
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
PRIMARY | |||
|
6YSS42VSEV
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
PRIMARY | |||
|
4570
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
PRIMARY | RxNorm | ||
|
37721
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
PRIMARY | |||
|
9250
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
PRIMARY | |||
|
DTXSID5023081
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
PRIMARY | |||
|
m5572
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
PRIMARY | Merck Index | ||
|
DB04173
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
PRIMARY | |||
|
57-48-7
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
PRIMARY | |||
|
D005632
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
PRIMARY | |||
|
1286504
Created by
admin on Wed Apr 02 11:53:36 GMT 2025 , Edited by admin on Wed Apr 02 11:53:36 GMT 2025
|
PRIMARY |
ACTIVE MOIETY